Antitumor agents

Details Antitumor agents Antitumor agents

A - Human Necessities

61

K

A61K 45/00 (2006.01) A61K 31/353 (2006.01) A61K 31/40 (2006.01) A61K 31/475 (2006.01) A61K 35/00 (2006.01) A61K 38/00 (2006.01) A61K 38/07 (2006.01) A61K 38/08 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2358491

When an antitumor agent acting on microtubule is used together with an ERK MAP kinase cascade blocking agent, the antitumor effect of the agent acting on microtubule can be remarkably potentiated. Namely, a combination of the agent acting on microtubule with the ERK MAP kinase cascade blocking agent is useful as an excellent antitumor agent with a remarkable efficacy.

Lorsqu'on utilise un agent antitumoral agissant sur un microtubule en association avec un agent de blocage en cascade de kinase ERK MAP, l'effet antitumoral de l'agent agissant sur le microtubule peut être remarquablement potentialisé. Ainsi, une combinaison de l'agent agissant sur un microtubule avec un agent de blocage en cascade de kinase ERK MAP est utile comme excellent agent antitumoral avec une efficacité remarquable.

Affiliated with

Also associated with

Rating

Antitumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1958744